Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Capstan Therapeutics, Inc.

Capstan Therapeutics Announces Initiation of Phase 1 Trial of Lead In Vivo CAR-T Therapy, CPTX2309, for Treating Autoimmune Disease
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics Presents Preclinical Data on Lead In Vivo CAR-T Candidate, CPTX2309, at American College of Rheumatology (ACR) Convergence 2024
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics to Participate in Upcoming Investor Conferences
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics to Participate in Upcoming Investor Conferences
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics to Participate in 45th Annual Goldman Sachs Global Healthcare Conference
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics Announces $175M Oversubscribed Series B Financing
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics Appoints Ramin Farzaneh-Far, M.D., as Chief Medical Officer and Announces Key Business Leadership Promotion
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics to Present Preclinical Data at SITC Demonstrating Rapid Anti-Primary B Cell and Anti-Tumor Activity in Mice with Proprietary Targeted Lipid Nanoparticles Delivering an Anti-CD19 CAR mRNA Construct
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics Co-Founder Drew Weissman, M.D., Ph.D., Awarded Nobel Prize in Physiology or Medicine for Enabling Rapid Development of RNA-based COVID-19 Vaccine
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics to Participate in Upcoming Industry Conferences
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics to Participate in Upcoming Investor Conferences
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics Appoints Justin Thacker as Chief Financial Officer and Jeffrey Pepe, J.D., Ph.D., as General Counsel
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics to Participate in Cowen 43rd Annual Health Care Conference
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics to Participate in SVB Securities 2023 Global Biopharma Conference
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics Announces Appointment of Athena Countouriotis, M.D., as Board Chair and Strengthens Leadership Team with Key Appointment
From Capstan Therapeutics, Inc.
Via Business Wire
Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering
From Capstan Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.